Executive Summary
The June 26, 2026, MCA Merger & Acquisition Tracker reveals a market dominated by strategic consolidation and corporate restructuring, with two high-materiality amalgamations (Krebs/Ipca and Kisan Mouldings/Apollo Pipes) driving the narrative. A clear theme of vertical integration and operational synergy is evident, as large players absorb loss-making subsidiaries to secure critical supply chains (fermentation-based APIs) and achieve economies of scale.
Concurrently, a wave of subsidiary incorporations by companies like NTPC, Powerica, and Sunteck signals targeted expansion into high-growth sectors (renewable energy, semiconductors, real estate). Insider activity presents a mixed picture: a promoter acquisition at Gamco Limited contrasts with a significant promoter sale at Gautam Exim, while a large inter-se gift transfer at Clean Science suggests internal wealth reorganization. The period-over-period data highlights a stark divergence, with high-growth targets like Penganga Sakhar (turnover surging ~495% over two years) being acquired, contrasting with stagnant performers like Bartisans (flat turnover). The overall sentiment is cautiously constructive, with the market rewarding clear strategic rationale in M&A while penalizing opaque or distressed consolidations.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Merger Acquisition MCA Regulatory Filings digest from June 25, 2026.
Investment Signals (10)
-
The amalgamation secures a critical fermentation-based API supply chain for Ipca's largest-selling formulation, with Krebs possessing a capability Ipca lacks. This vertical integration is a strategic moat, but Krebs is loss-making (₹26 Cr income vs Ipca's ₹7,431 Cr). The 7:200 share swap ratio is highly favorable for Ipca, offering a potential turnaround play with minimal dilution (promoter holding drops only 6 bps). [BULLISH for Ipca]
-
The scheme creates a combined entity with enhanced market competitiveness and operational synergies. Post-merger, APL's public shareholding will increase from 47.99% to 50.52%, improving governance. The 4.96:100 swap ratio offers KML shareholders a path to a larger, more liquid platform. However, the delisting of KML is a key risk for its minority holders. [BULLISH for Apollo Pipes]
- Pet Plastics (Bharatam Ventures) (BULLISH)▲
The acquisition of a 99.9987% stake in Penganga Sakhar Karkhana for ₹1.79 Cr is a high-upside diversification. The target's turnover exploded from ₹1,404 Lakh (FY24) to ₹8,352.89 Lakh (FY26), a ~495% growth, indicating a rapidly scaling sugar business. The low entry price relative to this growth trajectory presents a significant value-accretive opportunity.
- Gamco Limited ↓ (BULLISH)▲
Promoter Rashi Goenka's open market acquisition of 53,000 shares (0.10% stake) increasing her holding to 2.80% signals strong insider confidence. This is a direct vote of confidence in the company's future prospects, especially in a low-materiality filing environment.
- Powerica Ltd ↓ (BULLISH)▲
The incorporation of Windfusion Renewable Private Limited with a ₹25 Lakh investment is a clear strategic pivot into high-growth renewable energy (wind, solar, hybrid). This aligns with national green energy goals and could unlock significant long-term value, though near-term financial impact is negligible.
- Gautam Exim Limited ↓ (BEARISH)▲
Promoter Parmeshwar Ojha sold 5,01,000 shares (a 2.03% stake reduction from 11.40% to 9.37%) on the open market. This is a significant insider sell, indicating a lack of confidence or a need for liquidity, which is a clear bearish signal for minority shareholders.
- Tilaknagar Industries ↓ (BEARISH)▲
The additional ₹2 Cr investment in Bartisans (CCPS at ~₹12,752 per share) to reach a 41.45% stake is concerning given Bartisans' flat turnover of ₹3.5 Cr (same as FY24). This suggests the cocktail mixer business is struggling to scale, and TI is doubling down on a stagnant asset, raising questions about capital allocation.
-
The inter-se gift transfer of 18.86% of share capital (2,00,38,000 shares) to business trusts is a major internal reorganization. While it doesn't change ultimate control, it could be a precursor to estate planning, tax optimization, or future stake sales. The sheer size (nearly 1/5th of the company) warrants monitoring. [NEUTRAL with watch]
-
The incorporation of NTPC (Mauritius) Energy Limited for a Floating Solar PV + BESS project is a small (₹19.8 Lakh) but strategic move into international renewable energy. It signals NTPC's intent to export its expertise and could be the first of many such international project SPVs. [NEUTRAL/BULLISH long-term]
-
The incorporation of GFCL Semiconductor and Advanced Materials Limited is a high-conviction pivot into the semiconductor value chain. While the initial investment is only ₹1 Lakh, the strategic intent to design and manufacture integrated circuits and specialty chemicals positions GFCL for India's semiconductor push. [BULLISH long-term]
Risk Flags (8)
- Krebs Biochemicals (Financial Distress) [HIGH RISK]▼
The company is continuously loss-making with a total income of only ₹26 Cr. It is unable to fund R&D for new fermentation-based APIs, making it entirely dependent on the Ipca merger for survival. The scheme is a rescue merger, and execution risk is high.
- Tilaknagar Industries (Capital Allocation) [HIGH RISK]▼
The additional ₹2 Cr investment in Bartisans, which has flat turnover of ₹3.5 Cr (FY24 vs FY26), raises red flags. The company is injecting capital into a stagnant business with a net worth of only ₹1 Cr, suggesting poor capital allocation and potential value destruction.
- Gautam Exim (Promoter Exit) [HIGH RISK]▼
Promoter Parmeshwar Ojha's sale of a 2.03% stake in a single day is a significant de-risking event. Such a large open-market sale by a key insider is often a leading indicator of underlying business weakness or an impending negative event.
- Kisan Mouldings (Delisting Risk) [MEDIUM RISK]▼
The scheme of arrangement will result in the delisting of Kisan Mouldings Ltd. and the cancellation of all its equity shares. Minority shareholders who do not want Apollo Pipes shares will be forced to accept the swap or sell in the market, potentially at a discount.
- Cyber Media (India) (Regulatory Compliance) [MEDIUM RISK]▼
The NSE observation letter includes 20 specific compliance conditions (a through r) that must be met. Failure to adhere to any of these conditions could derail the merger scheme, which is already subject to NCLT approval. The 6-month validity of the NSE letter adds time pressure.
- Som Datt Finance (Promoter Reorganization) [LOW RISK]▼
The inter-se gift of 1.76% of paid-up capital from Dr. Bhaskara Rao Bollineni to Mr. Bhavanam Ruthvik Reddy, while exempt from open offer, shifts control within the promoter group. This could be a precursor to a larger change in management or control, creating uncertainty.
- Ipca Laboratories (Dilution & Integration) [MEDIUM RISK]▼
While the merger is strategic, integrating a loss-making entity (Krebs) with a vastly different scale (₹26 Cr vs ₹7,431 Cr income) poses operational and cultural challenges. The marginal dilution (promoter holding from 44.72% to 44.66%) is negligible, but the turnaround of Krebs is not guaranteed.
- Apollo Pipes (Shareholder Dilution) [MEDIUM RISK]▼
The issuance of 4.96 APL shares for every 100 KML shares will result in dilution for existing APL shareholders. While the scheme aims for synergies, the near-term impact on EPS and ROE needs to be monitored.
Opportunities (8)
- Pet Plastics (Bharatam Ventures) / Sugar Sector (OPPORTUNITY)◆
The acquisition of Penganga Sakhar (turnover growing ~495% in 2 years) for ₹1.79 Cr is a deep-value play. Investors should analyze the sustainability of this growth and the potential for further consolidation in the sugar sector, which is benefiting from ethanol blending mandates.
- Ipca Laboratories / API Security↓ (OPPORTUNITY)◆
The Krebs merger provides Ipca with a captive source of a critical fermentation-based API used in its largest-selling formulation. This vertical integration insulates Ipca from global supply chain disruptions and price volatility, a key competitive advantage in the pharma sector.
- Powerica Ltd / Renewable Energy SPV↓ (OPPORTUNITY)◆
The creation of Windfusion Renewable is a clean entry into the booming Indian renewable energy market. As a pure-play SPV, it could attract project-level financing or be spun off, unlocking value for Powerica shareholders.
- NTPC Limited / International Expansion↓ (OPPORTUNITY)◆
The Mauritius subsidiary is NTPC's first step into international renewable energy project development. This could be the template for a larger global push, potentially leading to higher valuations as NTPC transforms from a domestic thermal power giant to a global green energy player.
- Gujarat Fluorochemicals / Semiconductor Play↓ (OPPORTUNITY)◆
The incorporation of GFCL Semiconductor and Advanced Materials is a direct bet on India's semiconductor mission. If successful, this could be a multi-bagger opportunity, as the subsidiary could become a key player in the domestic semiconductor supply chain.
- Apollo Pipes / Market Consolidation↓ (OPPORTUNITY)◆
The merger with Kisan Mouldings creates a stronger, more diversified player in the pipes industry. The combined entity can achieve better pricing power, cost efficiencies (economies of scale), and a wider distribution network, making it a more formidable competitor.
- Gamco Limited / Insider Buying↓ (OPPORTUNITY)◆
The promoter's open market purchase is a strong signal. Investors should investigate the company's fundamentals to see if there is a catalyst (e.g., new order, product launch) that justifies this confidence.
- Cyber Media (India) / Simplified Structure↓ (OPPORTUNITY)◆
The merger of its subsidiary CMRSL will simplify the corporate structure, reduce compliance costs, and provide better cash flow visibility. Once the NCLT approval is received, the stock could re-rate as the complexity discount is removed.
Sector Themes (6)
- Vertical Integration in Pharma◆
The Ipca-Krebs merger is a textbook example of a large player acquiring a distressed but strategically critical supplier. This trend is likely to continue as Indian pharma companies seek to secure API supply chains and reduce dependence on China. Expect more such rescue/takeover mergers in the API space.
- Consolidation in Pipes & Plastics◆
The Apollo Pipes-Kisan Mouldings scheme signals a consolidation wave in the Indian pipes industry. Smaller, fragmented players are merging with larger ones to achieve scale, better raw material pricing, and wider distribution. This is a positive for industry leaders like APL and a risk for standalone small players.
- Renewable Energy SPV Creation◆
Multiple companies (NTPC, Powerica) are incorporating wholly-owned subsidiaries specifically for renewable energy projects. This trend of creating ring-fenced SPVs is a standard practice to isolate project risk, attract green financing, and potentially unlock value through separate listings or stake sales.
- Insider Activity Divergence◆
The data shows a clear divergence in insider sentiment. While promoters at Gamco are buying, the significant sale at Gautam Exim is a red flag. This suggests a stock-specific rather than a sector-wide trend, emphasizing the need for bottom-up analysis.
- Distressed Asset Acquisition◆
Both the Ipca-Krebs and Pet Plastics-Penganga Sakhar deals involve acquiring distressed or small, high-growth assets at attractive valuations. This 'buying on the cheap' strategy is a recurring theme, offering high returns for acquirers with strong balance sheets and turnaround capabilities.
- Corporate Simplification via Merger◆
Cyber Media's merger of its subsidiary is part of a broader trend of corporate simplification. Companies are collapsing complex holding structures to improve governance, reduce costs, and enhance shareholder returns. This is a positive signal for minority shareholders.
Watch List (8)
-
Watch for NCLT approval and the timeline for the scheme's effective date. Key metric: Krebs' revenue and margin trajectory post-merger. The earnings call post-merger will be critical.
-
Monitor the shareholder voting and NCLT approval process. Key metric: APL's stock price performance relative to the swap ratio (4.96:100) to gauge market reception.
-
Watch for further insider selling or any adverse corporate announcements. The promoter's sale of 2.03% stake is a major red flag. Monitor Q1 FY27 results for any signs of business deterioration.
-
Monitor the 18.86% inter-se transfer to business trusts. Watch for any subsequent off-market transactions or changes in shareholding patterns that could signal a future stake sale.
- NTPC (Mauritius) Energy Limited👁
Watch for the first project announcement or financial commitment. This will be a key indicator of NTPC's international renewable energy ambitions.
-
Monitor for any project wins or partnerships. The subsidiary's ability to secure land and power purchase agreements (PPAs) will be a key value driver.
-
Watch for Bartisans' next financial results. If turnover remains stagnant despite the fresh ₹2 Cr infusion, it will confirm poor capital allocation and could lead to a further de-rating of TI's stock.
-
Watch for any announcements regarding technology partnerships, talent acquisition, or government incentives (PLI scheme) for the new subsidiary.
Filing Analyses
(15)
26-06-2026
Cyber Media (India) Limited (CMIL) has received 'no adverse observations' from BSE and a 'No objection' letter from NSE for its proposed scheme of merger by absorption of its subsidiary Cyber Media Research & Services Limited (CMRSL) into CMIL. The observation letters, dated June 25, 2026, were received on June 26, 2026, and include several compliance conditions from SEBI, such as ensuring the scheme complies with LODR regulations, disclosing ongoing enforcement actions, and providing detailed financial and risk information to shareholders. The scheme remains subject to further regulatory approvals, including from the NCLT, and the NSE observation letter is valid for six months.
- · The observation letters were received from BSE and NSE on June 25, 2026, and the company intimated the stock exchanges on June 26, 2026.
- · The NSE observation letter includes 20 specific compliance conditions (a through r) that the companies must adhere to.
- · The NSE observation letter is valid for six months from June 25, 2026, within which the scheme must be submitted to NCLT.
- · The scheme was initially approved by the Board on January 24, 2026, and the application was filed with BSE and NSE on January 31, 2026.
- · The observation letters are available on the company's websites: https://cybermedia.co.in/ and https://www.cmrsl.net/.
26-06-2026
Tilaknagar Industries Limited (TI) has approved a further investment of ₹2 Crore in Round the Cocktails Private Limited (Bartisans) by subscribing to 1,569 Compulsory Convertible Preference Shares at ₹12,752 per CCPS. Post investment, TI's stake in Bartisans will increase to 41.45%. Bartisans, a ready-to-pour cocktail mixer company, reported flat turnover of ₹3.5 Cr in FY26 (same as FY24) and net worth of ₹1.0 Cr, indicating stagnant top-line performance despite TI's continued backing.
- · Bartisans was incorporated on 19-Aug-2021.
- · The investment is a cash consideration transaction.
- · Completion of the acquisition is expected on or before 31st August 2026.
- · The transaction is at arm's length and does not involve related parties.
- · Bartisans' net worth as of March 31, 2026 is only ₹1.0 Crore, indicating a thin equity base.
- · No governmental or regulatory approvals are required for the acquisition.
26-06-2026
Gujarat Fluorochemicals Limited (GFCL) has incorporated a wholly-owned subsidiary, GFCL Semiconductor and Advanced Materials Limited, on June 26, 2026, in India. The subsidiary will operate in specialty chemicals and semiconductor devices, including integrated circuits. The company subscribed to equity shares at a cost of ₹1 Lakh, representing 100% shareholding.
- · The subsidiary is incorporated in India.
- · The subsidiary's business includes designing, developing, manufacturing, and dealing in specialty chemicals, semiconductor devices, integrated circuits, electronic components, software, and related technologies.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration is in cash.
26-06-2026
Powerica Ltd announced the incorporation of a wholly owned subsidiary, Windfusion Renewable Private Limited, on June 26, 2026, with the approval of the Ministry of Corporate Affairs. The subsidiary is focused on renewable energy projects including wind, solar, and hybrid power. Powerica subscribed to 100% of the subsidiary's paid-up share capital (250,000 equity shares at ₹10 each) for a total cash consideration of ₹2,500,000.
- · The subsidiary is incorporated in India under the Companies Act.
- · The subsidiary's main objects include setting up and developing wind, solar, wind-solar hybrid, and other renewable power projects.
- · No governmental or regulatory approvals were required for the incorporation beyond the Ministry of Corporate Affairs approval.
- · The consideration is in cash and the listed entity holds 100% control over the WOS.
26-06-2026
Sunteck Realty Limited has incorporated a wholly-owned subsidiary, Eminara Buildcon Private Limited (EBPL), on June 26, 2026, for real estate activities. The company subscribed to 10,000 equity shares of ₹10 each for a total cash consideration of ₹1,00,000, resulting in 100% ownership. This is a routine corporate structuring move with no related-party or regulatory approval implications.
- · The subsidiary is incorporated in India and classified under the real estate industry.
- · No governmental or regulatory approvals were required for the incorporation.
- · The transaction is not a related-party transaction, and no promoter/group entities have an interest in EBPL.
26-06-2026
Bharatam Ventures Limited (formerly Pet Plastics Ltd.) completed the acquisition of a 99.9987% equity stake in Penganga Sakhar Karkhana Private Limited for a cash consideration of ₹1,79,99,760 (₹1.79 Crore). The target company is engaged in sugar manufacturing and allied agro-processing, with turnover growing from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26. The acquisition is a strategic diversification into the sugar sector, but no financial details of the acquirer or funding sources were disclosed.
- · The acquisition was completed on June 26, 2026, following a disclosure on May 28, 2026.
- · The target company's turnover grew from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26, showing rapid growth.
- · The acquisition is not a related party transaction and was done on an arm's length basis.
- · No governmental or regulatory approvals are pending post-completion.
26-06-2026
Rashi Goenka, a promoter group member of GAMCO LIMITED, acquired 53,000 equity shares (0.10% of total capital) via open market transactions on June 24-25, 2026, increasing her holding from 2.70% to 2.80% of the paid-up equity share capital. The acquisition was disclosed under SEBI SAST Regulations.
- · Face value of each equity share is Rs. 2/-.
- · Acquisition was made through open market transactions over two days (24-06-2026 to 25-06-2026).
- · Total diluted share capital after acquisition is Rs. 10,80,63,000/- consisting of 5,40,31,500 equity shares.
26-06-2026
Clean Science and Technology Limited reported an inter-se transfer of 2,00,38,000 equity shares (representing 18.86% of the company's share capital) among promoters and promoter group members by way of gift, with no consideration involved. The transfers were executed from Ashok Ramnarayan Boob, Asha Ashok Boob, and Nilima Krishnakumar Boob to ARB Business Trust, AAB Business Trust, Asha Ashok Boob, and Alaknanda Business Trust. As this is a reorganisation of holdings within the promoter group with no change in ultimate control, the filing is procedural in nature and does not reflect a change in corporate ownership or financial performance.
- · Transfers were executed via off-market inter-se gift without any consideration.
- · The transfers are made under Regulation 10(1)(a)(ii) of the SEBI SAST Regulations.
- · The total transferred shares amount to 18.86% of the company's share capital.
- · Prior intimations were filed on 1st June 2026 (Reg 10(5)) and 10th/11th June 2026 (Reg 10(6)).
- · The disclosures were submitted on the SEBI Intermediary Portal (SI Portal) with application numbers 684, 701, 702, and 683 between 22–23 June 2026.
26-06-2026
The Board of Krebs Biochemicals & Industries Limited has approved a scheme of amalgamation with Ipca Laboratories Limited, with an appointed date of April 1, 2026. Under the scheme, Krebs (total income ₹26 Cr, loss-making) will be merged into Ipca (total income ₹7,431 Cr) in a share-for-share swap of 7 Ipca shares for every 200 Krebs shares, with no cash consideration. The merger aims to secure supply of a critical fermentation-based API and drug intermediates, while leveraging Ipca's financial strength to revive Krebs' R&D and manufacturing capabilities.
- · Krebs is continuously incurring losses and cannot fund R&D for new fermentation-based APIs.
- · Ipca does not have a fermentation-based API manufacturing capability, which Krebs possesses.
- · Krebs produces one fermentation-based API used in Ipca’s largest selling formulation, with only a handful of global manufacturers.
- · Krebs also produces few drug intermediates used in Ipca’s key APIs.
- · The transaction is a related party transaction and is being done at arm’s length.
- · The board meeting started at 11:30 a.m. and concluded at 1:00 p.m. on June 26, 2026.
26-06-2026
Ipca Laboratories Limited has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd., its subsidiary, to achieve operational synergies, secure supply of critical fermentation-based APIs and drug intermediates, and enable R&D for new fermentation-based products. The transaction involves a share-swap ratio of 7 equity shares of Ipca for every 200 shares of Krebs, with no cash consideration, and will result in a marginal reduction in promoter shareholding from 44.72% to 44.66%. However, Krebs has been incurring continuous losses (total income of only Rs. 26 Crores versus Ipca's Rs. 7431 Crores, mostly from conversion charges) and the amalgamation aims to leverage Ipca's financial strength to turn around the business.
- · Krebs Biochemicals & Industries Ltd. has been continuously incurring losses and is unable to invest in R&D for new fermentation-based APIs.
- · The appointed date for the Scheme is 1st April 2026, effective upon receipt of all approvals.
- · The share exchange ratio is 7 equity shares of Re.1 each of Ipca for every 200 fully paid-up equity shares of Rs.10 each held in Krebs.
- · Equity and preference shares of Krebs held by Ipca shall be cancelled with no consideration issued.
- · Post-scheme promoter shareholding reduces marginally from 44.72% to 44.66% (a drop of only ~0.06 percentage points).
- · Public shareholding increases from 55.28% to 55.34%.
- · Krebs holds a manufacturing facility capable of producing fermentation-based APIs, a capability Ipca currently lacks.
- · Krebs supplies one fermentation-based API used in Ipca's largest-selling formulation, and only a handful of manufacturers exist globally for this API.
26-06-2026
Kisan Mouldings Limited (KML) has approved a two-stage Scheme of Arrangement to amalgamate first its wholly owned subsidiary KML Tradelinks Private Limited (KTPL) into itself, and then amalgamate KML into Apollo Pipes Limited (APL). The scheme, effective from April 1, 2026, will see KML shareholders receive 4.96 equity shares of APL for every 100 shares held. The combined entity aims to achieve operational synergies, economies of scale, and enhanced market competitiveness, though the transaction will result in the delisting of KML and the cancellation of its equity shares.
- · The appointed date for the scheme is April 1, 2026.
- · KML's promoter shareholding pre-arrangement was 70.56% (8,42,87,623 shares); post-arrangement, all KML shares are cancelled.
- · APL's promoter shareholding post-arrangement will be 49.20% (2,27,80,000 shares) compared to 51.72% pre-arrangement, while public shareholding will increase from 47.99% to 50.52%.
- · The share exchange ratio is 4.96 equity shares of APL (face value ₹10 each) for every 100 equity shares of KML (face value ₹10 each).
- · KTPL has zero turnover and negligible net worth (₹0.02 Cr), making its amalgamation a purely structural step.
- · The scheme is subject to approvals from shareholders, creditors, stock exchanges, SEBI, NCLT, and other regulatory authorities.
26-06-2026
Apollo Pipes Limited (APL) announced a Scheme of Arrangement to amalgamate its wholly-owned step-down subsidiary KML Tradelinks (KTPL) into Kisan Mouldings (KML), and then KML into APL. APL will issue 4.96 equity shares for every 100 shares held in KML. The scheme aims to achieve operational synergies, cost reduction, and a stronger market presence, but comes with significant regulatory approvals and potential dilution for existing APL shareholders.
- · Appointed date for the scheme: April 1, 2026
- · The first step amalgamation (KTPL into KML) involves no issuance of shares as KTPL is a wholly owned subsidiary of KML.
- · The second step amalgamation (KML into APL) share exchange ratio: 4.96 APL shares for every 100 KML shares (face value ₹10 each).
- · Fairness opinion on share exchange ratio provided by Corporate Professionals Capital Private Limited (SEBI registered Category-I Merchant Banker).
- · Registered Valuer for valuation report: Axiology Valuetech Private Limited (IBBI registered).
- · The scheme requires approvals from shareholders, creditors, BSE, NSE, SEBI, and NCLT.
- · KML's promoter holding in APL post-arrangement becomes public holding, leading to promoter dilution from 51.72% to 49.20% in APL.
- · KML shareholders receive APL shares, thus the public shareholding in APL increases from 47.99% to 50.52%.
26-06-2026
NTPC Limited has incorporated a new wholly owned subsidiary, NTPC (Mauritius) Energy Limited, in Mauritius on June 26, 2026, to develop a Floating Solar Photovoltaic (FSPV) project with Battery Energy Storage System (BESS) and pursue other power sector businesses in Mauritius. The subsidiary is capitalized at MUR 1,000,000 (approx. INR 19,80,000) and is a newly incorporated entity with no current turnover. This is a small initial investment for a project development vehicle, with no financial returns expected in the near term.
- · The subsidiary was incorporated pursuant to the disclosure made on 23rd December 2025.
- · The entity is a wholly owned subsidiary of NTPC Limited.
- · No governmental or regulatory approvals have been mentioned as required; the filing lists Ministry of Power, DIPAM, and Registrar of Companies, Mauritius as likely approval bodies.
- · The consideration for acquisition is subscribed in cash.
26-06-2026
Promoter and Director Parmeshwar Ojha sold 5,01,000 equity shares of Gautam Exim Limited on June 24, 2026, reducing his stake from 11.40% to 9.37% of the company. The sale was executed on the BSE via a market transaction, and the disclosure was filed under SEBI Takeover and Insider Trading regulations.
- · The sale was executed on June 24, 2026, and the disclosure was filed on June 26, 2026.
- · The transaction was a market purchase/sale on the BSE.
- · No derivative contracts (futures or options) were held or traded by the promoter.
- · The promoter's remaining shareholding post-sale is 9.37% of the company.
26-06-2026
Crescentis Capital Limited (formerly Som Datt Finance Corporation Ltd.) disclosed an inter-se transfer of 3,00,000 equity shares (1.76% of paid-up capital) within its promoter group via a gift transaction on June 24, 2026. Dr. Bhaskara Rao Bollineni transferred the shares to Mr. Bhavanam Ruthvik Reddy, reducing his holding from 68.80% to 67.04%, while Mr. Reddy's stake increased from 6.17% to 7.94%. The aggregate promoter group shareholding remains unchanged, and the transaction is exempt from open offer requirements under SEBI Takeover Regulations.
- · The transaction was executed off-market by way of gift on June 24, 2026.
- · Disclosures were received from both parties on June 24, 2026, and filed with BSE on June 26, 2026.
- · The company's registered office is at 8-2-502/1/A, Ground Floor, JIVI Towers, Road No 7, Banjara Hills, Hyderabad - 500034.
- · The company was formerly known as Som Datt Finance Corporation Ltd.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 15 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Merger Acquisition MCA Regulatory Filings
June 24, 2026
India Merger Acquisition MCA Regulatory Filings — June 24, 2026
June 23, 2026
India Merger Acquisition MCA Regulatory Filings — June 23, 2026
June 22, 2026
India Merger Acquisition MCA Regulatory Filings — June 22, 2026
June 20, 2026
India Merger Acquisition MCA Regulatory Filings — June 20, 2026
🇮🇳 More from India
View all →June 27, 2026
India Pre-Market Regulatory Roundup — June 27, 2026
India Pre-Market Regulatory Roundup
June 27, 2026
India Quarterly Results BSE NSE Announcements — June 27, 2026
India Quarterly Results BSE NSE Announcements
June 27, 2026
India Upcoming Corporate Actions BSE NSE — June 27, 2026
India Upcoming Corporate Actions BSE NSE
June 27, 2026
BSE Sensex 30 Stocks Regulatory Filings — June 27, 2026
BSE Sensex 30 Stocks Regulatory Filings